Feb 09, 2021 10:33 PM IST

Buy Strides Pharma Science; target of Rs 1020: Sharekhan

Sharekhan is bullish on Strides Pharma Science has recommended buy rating on the stock with a target price of Rs 1020 in its research report dated February 04, 2021.

Lupin: New launches and market share gains are likely to override pricing erosion

New launches in the US, particularly in the inhalation category, and an improving market share are expected to help ride over structural pricing erosion in the near term for Lupin

Buy Strides Pharma Sciences; target of Rs 864: Sharekhan

Sharekhan is bullish on Strides Pharma Sciences recommended buy rating on the stock with a target price of Rs 864 in its research report dated October 29, 2020.

Buy Strides Pharma Science: target of Rs 710: ICICI Securities

ICICI Securities is bullish on Strides Pharma Science recommended buy rating on the stock with a target price of Rs 710 in its research report dated September 03, 2020.

Accumulate Strides Pharma Science; target of Rs 621: Geojit

Geojit recommended accumulate rating on Strides Pharma Science with a target price of Rs 621 in its research report dated August 07, 2020.

Buy Strides Pharma; target of Rs 650: Motilal Oswal

Motilal Oswal is bullish on Strides Pharma recommended buy rating on the stock with a target price of Rs 650 in its research report dated August 06, 2020.

Buy Strides Pharma Science; target of Rs 421: ICICI Securities

ICICI Securities is bullish on Strides Pharma Science has recommended buy rating on the stock with a target price of Rs 421 in its research report dated May 21, 2020.

Ranitidine controversy: Which Indian pharma companies stand to lose?

Ideas for Profit | An API company that combines good growth prospects with reasonable valuations

Buy Strides Pharma; target of Rs 635: Motilal Oswal

Motilal Oswal is bullish on Strides Pharma has recommended buy rating on the stock with a target price of Rs 635 in its research report dated May 11, 2019.

Buy Strides Pharma Science; target of Rs 530: Geojit

Geojit is bullish on Strides Pharma Science has recommended buy rating on the stock with a target price of Rs 530 in its research report dated January 31, 2019.

Buy Strides Pharma; target of Rs 590: Motilal Oswal

Motilal Oswal is bullish on Strides Pharma has recommended buy rating on the stock with a target price of Rs 590 in its research report dated January 29, 2019.

Buy Strides Shasun; target of Rs 481: Motilal Oswal

Motilal Oswal is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 481 in its research report dated August 08, 2018.

Buy Strides Shasun; target of Rs 480: HDFC Securities

HDFC Securities is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 480 in its research report dated 09 Aug 2018.

Buy Strides Shasun; target of Rs 530: JM Financial

JM Financial is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 530 in its research report dated May 21, 2018.

Buy Strides Shasun; target of Rs 980: HDFC Securities

HDFC Securities is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 980 in its research report dated May 10, 2018.

Buy Strides Shasun; target of Rs 1200: HDFC Securities

HDFC Securities is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1200 in its research report dated 21 November 2017.

Buy Strides Shasun; target of Rs 1201: Motilal Oswal

Motilal Oswal is bullish on Strides Shasun has recommended Buy rating on the stock with a target price of Rs 1201 in its research report dated October 31, 2017.

Buy Strides Shasun; target of Rs 1300: Motilal Oswal

Motilal Oswal is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated September 12, 2017.

Buy Strides Shasun; target of Rs 1030: Axis Direct

Axis Direct is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1030 in its research report dated August 18, 2017.

Buy Strides Shasun; target of Rs 1,200: Axis Direct

Axis Direct is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1,200 in its research report dated Jun 22, 2017.

Buy Strides Shasun; target of Rs 1340: Axis Direct

Axis Direct is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1340 in its research report dated February 09, 2017.

Here are Prakash Diwan's top trading ideas

In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, Prakash Diwan of Altamount Capital Management shared his reading and outlook on the market and also gave recommendations on various stocks.

Hold Strides Shasun; target of Rs 1190: Religare

Religare recommended hold rating on Strides Shasun with a target price of Rs 1190 in its research report dated October 28, 2016.

Hold Strides Shasun; target of Rs 1130: Religare

Religare recommended hold rating on Strides Shasun with a target price of Rs 1130 in its research report dated August 17, 2016.